title: Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Authors' reply.
authors.affiliation: Department of Medicine, Køge University Hospital, Køge, Denmark. loedrup.ab@gmail.com.|Diagnostic Center, Silkeborg Hospital, Silkeborg, Denmark. loedrup.ab@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Lødrup
authors.affiliation: Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense, Denmark.
authors.forename: A
authors.initials: A
authors.lastname: Pottegård
authors.affiliation: Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense, Denmark.|Department of Clinical Chemistry & Pharmacology, Odense University Hospital, Odense, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Hallas
authors.affiliation: Department of Medicine, Køge University Hospital, Køge, Denmark.|Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
authors.forename: P
authors.initials: P
authors.lastname: Bytzer
mesh_terms: D004305:Dose-Response Relationship, Drug; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000601:surgery*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D054328:Proton Pump Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors